当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 现金流量表

博瑞医药

(688166)

  

流通市值:219.51亿  总市值:219.51亿
流通股本:4.23亿   总股本:4.23亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金765,591,648.78520,621,567.05275,672,789.11,010,560,886.9
  收到的税费返还35,253,379.7730,178,607.0326,337,116.3956,504,504.16
  收到其他与经营活动有关的现金21,332,885.3911,591,785.5215,897,264.3550,805,215.96
  经营活动现金流入小计822,177,913.94562,391,959.6317,907,169.841,117,870,607.02
  购买商品、接受劳务支付的现金200,576,314.96115,408,176.1258,550,490.52204,463,410.07
  支付给职工以及为职工支付的现金215,274,981.42153,579,704.2165,357,589.92265,530,091.9
  支付的各项税费47,379,464.9534,678,294.5823,387,168.2881,969,233.46
  支付其他与经营活动有关的现金259,992,290.8145,113,003.6863,618,928.61320,348,554.49
  经营活动现金流出小计723,223,052.13448,779,178.59210,914,177.33872,311,289.92
  经营活动产生的现金流量净额98,954,861.81113,612,781.01106,992,992.51245,559,317.1
二、投资活动产生的现金流量:
  收回投资收到的现金46,705,10046,705,100-110,170,515.34
  取得投资收益收到的现金---1,579,324.87
  处置固定资产、无形资产和其他长期资产收回的现金净额19,194.4217,664.426,160303,641.61
  收到的其他与投资活动有关的现金---43,788,077.6
  投资活动现金流入小计46,724,294.4246,722,764.426,160155,841,559.42
  购建固定资产、无形资产和其他长期资产支付的现金363,386,304.78327,294,945.44221,710,325.76257,199,197.47
  投资支付的现金235,907,061.74106,730,462.885,593,449.23338,783,886.09
  投资活动现金流出小计599,293,366.52434,025,408.32227,303,774.99595,983,083.56
  投资活动产生的现金流量净额-552,569,072.1-387,302,643.9-227,297,614.99-440,141,524.14
三、筹资活动产生的现金流量:
  吸收投资收到的现金181,800,000181,800,000181,800,000103,000,000
  其中:子公司吸收少数股东投资收到的现金181,800,000181,800,000181,800,000103,000,000
  取得借款收到的现金613,202,925.81496,899,300316,351,900802,077,074.15
  收到其他与筹资活动有关的现金170,000,00070,000,00020,000,00021,000,000
  筹资活动现金流入小计965,002,925.81748,699,300518,151,900926,077,074.15
  偿还债务支付的现金549,850,506.34409,263,943.65319,943,643.65786,710,467.93
  分配股利、利润或偿付利息支付的现金92,923,459.8580,139,714.6120,113,633.68135,734,274.41
  支付其他与筹资活动有关的现金28,563,030.7415,184,5028,703,637.2228,107,235.67
  筹资活动现金流出小计671,336,996.93504,588,160.26348,760,914.55950,551,978.01
  筹资活动产生的现金流量净额293,665,928.88244,111,139.74169,390,985.45-24,474,903.86
四、汇率变动对现金及现金等价物的影响6,062,765.146,309,982.473,123,026.272,118,247.62
五、现金及现金等价物净增加额-153,885,516.27-23,268,740.6852,209,389.24-216,938,863.28
  加:期初现金及现金等价物余额754,101,930.95754,101,930.95754,101,930.95971,040,794.23
  期末现金及现金等价物余额600,216,414.68730,833,190.27806,311,320.19754,101,930.95
补充资料:
  净利润-1,657,076.47-141,263,284.54
  资产减值准备-2,766,161.91-19,942,512.38
  固定资产和投资性房地产折旧-68,653,413.53-91,406,078.94
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,653,413.53-91,406,078.94
  无形资产摊销-2,991,127.05-5,877,357.74
  长期待摊费用摊销-6,014,313.45-9,187,226.6
  处置固定资产、无形资产和其他长期资产的损失---0
  固定资产报废损失-208,240.64-148,435.21
  公允价值变动损失--1,585,851.81-5,699,782.83
  财务费用-22,569,997.3-50,515,554.66
  投资损失-5,427,848.31-11,633,803.45
  递延所得税--8,009,207.93--31,266,124.51
  其中:递延所得税资产减少--8,009,207.93--31,266,124.51
    递延所得税负债增加---0
  存货的减少--10,571,118.75--35,549,548.22
  经营性应收项目的减少-61,037,558.21--149,927,051.69
  经营性应付项目的增加--46,429,041.47-84,399,593.34
  其他---0
  债务转为资本---0
  一年内到期的可转换公司债券---0
  融资租入固定资产---0
  现金的期末余额-730,833,190.27-754,101,930.95
  减:现金的期初余额-754,101,930.95-971,040,794.23
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额--23,268,740.68--216,938,863.28
公告日期2025-10-312025-08-292025-04-182025-04-03
审计意见(境内)标准无保留意见
TOP↑